Skip to main content

Stifel Nicolaus downgrades Quipt Home Medical (QIPT) to a Sell

Tipranks - Tipranks - Wed Dec 17, 2025

Stifel Nicolaus analyst Justin Keywood downgraded Quipt Home Medical to a Sell yesterday and set a price target of C$5.10. The company’s shares closed yesterday at C$4.65.

Claim 50% Off TipRanks Premium and Invest with Confidence

According to TipRanks, Keywood is an analyst with an average return of -5.3% and a 43.91% success rate. Keywood covers the Healthcare sector, focusing on stocks such as WELL Health Technologies Corp, Vitalhub, and HEALWELL AI.

Quipt Home Medical has an analyst consensus of Hold, with a price target consensus of C$5.31.

See today’s best-performing stocks on TipRanks >>

Based on Quipt Home Medical’s latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of C$58.29 million and a GAAP net loss of C$3.03 million. In comparison, last year the company earned a revenue of C$63.97 million and had a GAAP net loss of C$1.7 million

Read More on TSE:QIPT:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).